Inhaled bispecific single-domain antibody BM219 for mild-to-moderate COVID-19: a double-blind, randomized,

Yanling Wu1, Yuan Li2, Ping Zhang2

  • 1Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Department of Pulmonary and Critical Care Medicine, Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China. yanlingwu@fudan.edu.cn.

Cell Discovery
|July 17, 2025
PubMed
Abstract

No abstract available in PubMed .